1Matteo Pirro,Pascale Mauriege,Andre Tchernof,et al.Plasma free acid levels and the risk of ischemic heart disease in men: prospective results from Quebec Cardiovascular Study[].Atherosclerosis.2002
2Kendall DM,Harmel AP.The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance[].American Journal of Managed Care.2002
4Melvin R Hayden,Suresh C Tyagi.Intimal redox stresss: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus.Atheroscleropathy[].Cardiovascular Diabetology.2002
5Peter Libby,Paul M.Ridker, and Attilio Maseri.Inflammation and atherosclerosis[].Circulation.2002
4SCHWARTZ E A, REAVEN P D. Molecular and signaling mechanism of atherosclerosis in insulin re sistance[J]. Endocrinol Metab Clin North Am, 2006, 35:525-549.
5FESTA A D, AGOSTION R J R, HOWARD G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin restance athero-sclerosis study (IRSA)[J]. Circulation, 2000, 102: 42-47.
6ALEXANDRKIK, PIPER I C, KALOFOUTIS C, et al. Inflammatory process in type 2 diabetes: The role of cytokines[J]. Ann N Y Aead Sei, 2006,1084: 89 -117.
7WALLACE T M, MATTHEWS D R. The assessment of insulin resistance in man[J]. Diabet Med, 2002,19:527-534.
8Caramori PR, Lima VC, Seidelin PH, et al. Long-term endothelial dysfunction after coronary artery stenting. J Am Coll Cardiol, 1999,34:1675-1679.
9Greer IA, Ieask R, Hodson B A, et al. Endothelin elauase and endothelin dysfunction in preedlampsia. Lancet, 1991,337:558.
10Vaddi K, Nicolini FA, Mechta P, et al. Endothdial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol, 1999,34:1452-1460.
